Decreased CNS inflammation and absence of clinical exacerbation of disease after six months oral administration of bovine myelin in diseased SJL/J mice with chronic relapsing experimental autoimmune encephalomyelitis

Journal of Neuroscience Research

Volumn 45, Issue 4, 1996, Pages 424-429

  Al Sabbagh, Ahmad M ^a   Goad, E P ^c   Weiner, H L ^b   Nelson, P A ^a  

^a AutoImmune Inc   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

chronic relapsing experimental autoimmune encephalomyelitis; myelin; oral tolerance therapy

Indexed keywords

AUTOANTIGEN; MYELIN BASIC PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MEDIATED CYTOTOXICITY; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; DEMYELINATION; DRUG EFFECT; DRUG TOLERANCE; HISTOLOGY; IMMUNE RESPONSE; INFLAMMATORY CELL; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RELAPSE;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODY FORMATION; CATTLE; CHRONIC DISEASE; DEMYELINATING DISEASES; DISEASE PROGRESSION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; MICE; MICE, INBRED STRAINS; MYELIN BASIC PROTEINS; MYELIN PROTEOLIPID PROTEIN; RECURRENCE; TIME FACTORS;

EID: 0029757413     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19960815)45:4<424::AID-JNR11>3.0.CO;2-0     Document Type: Article

References (14)

1. Brod SA, Al-Sabbagh A, Sobel RA, Hafler DA, Weiner HL (1991): Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens. IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig. Ann Neurol 29:615-622.
2. Brown AM, McFarlin DE (1981): Relapsing experimental encephalomyelitis in the SJL/J mouse. Lab Invest 45:278-284.
3. Chen Y, Kuchroo VK, Inobe J-i, Hafler DA, Weiner HL (1994): Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalitis. Science 265:1237-1240.
4. Deibler GE, Martenson RE, Kies MW (1972): Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep Biochem 2:139-165.
5. Friedman A, Weiner HL (1994): Induction of anergy or active suppression following oral tolerance is determined by frequency of feeding and antigen dosage. Proc Natl Acad Sci USA 91:6688-6692.
6. Higgins P, Weiner HL (1988): Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J Immunol 140:440-445.
7. Hohol MJ, Khoury SJ, Cook SL, Orav EJ, Hafler DA, Weiner HL (1996): Three-year open protocol continuation study of oral tolerization with myelin antigens in multiple sclerosis and design of a phase III pivotal trial. In Weiner HL, Mayer LF (eds): "Oral Tolerance: Mechanisms and Applications," Vol. 778. New York: New York Academy of Sciences, pp 243-250.
8. Lees MB, Sakura JD (1979): Preparation of proteolipids. In Marks N, Rodnight R (eds): "Research Methods in Neurochemistry." New York: Plenum Press, p 354.
9. McRae BL, Miller SD (1994): Fine specificity of CD4 + T cell to the dominant encephalitogenic PLP 139-151 peptide in SJL/J mice. Neurochem Res 19:997-1004.
10. Nagler-Anderson C, Bober LA, Robinson ME, Siskind GW, Thorbecke FJ (1986): Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc Natl Acad Sci USA 83:7443-7446.
11. Thompson HSG, Harper N, Bevan DJ, Staines NA (1993): Suppression of collagen induced arthritis by oral administration of type II collagen: changes in immune and arthritic responses mediated by active peripheral suppression. Autoimmunity 16:189-199.
12. Weiner HL, Mackin GA, Matsui M, Orav EJ, Khoury SJ, Dawson DM, Hafler DA (1993): Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 259: 1321-1324.
13. Weiner HL, Friedman A, Miller A, Khoury SJ, Al-Sabbagh A, Santos L, Sayegh M, Nussenblatt RB, Trentham DE, Hafler DA (1994): Oral tolerance: immunologic mechanisms and treatment of animal and human organ specific autoimmune diseases by oral administration of autoantigens. Ann Rev Immunol 12: 809-837.
14. Whitham RH, Bourdett DN, Hashim GA, Herndon RM, IIg RC, Vandenbark AA, Offner H (1991): Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis. J Immunol 146: 101-107.